Dr. Harris is Associate Professor of Medical Oncology at the University of Washington School of Medicine and the Clinical Research Division, Fred Hutchinson Cancer Center (Seattle, WA). He designs and conducts Phase I-III clinical trials in hepatobiliary cancers, focusing on targeted therapy, immunotherapy, and novel combinations. As the senior oncologist in the large multi-disciplinary FLC team in Seattle, Dr. Harris has extensive hands-on experience treating FLC patients and an active interest in developing improved therapies. He contributes to reviewing grant applications for the FCF, and he co-chairs the Foundation’s Translational Working Group.